Status: Recruiting
A Study of Automated Axicabtagene Ciloleucel for R/R Large B-cell Lymphoma.
This study is a single-arm, multicenter, open-label clinical study evaluating the efficacy and safety of axicabtagene ciloleucel injection manufactured by an automated cell preparation process in adult subjects with relapsed or refractory large B-cell lymphoma (r/r LBCL) as second-line therapy.
Participants needed: 12
Trial details
Phase: Early Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Shenzhen Fosun Kairos Biotechnology Co., Ltd.Updated: Jun 5, 2026Locations: 6
Eligibility criteria
Age 18 years or older at the time of informed consent [+10]
Prior history of other malignancies, with the exception of non-melanoma skin tum... [+19]